NCT04123457View on ClinicalTrials.gov

Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema

Enrolling by invitationOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions

Lymphedema

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT04123457 - Biorepository of Biomarkers for Optimization of Microvascular Treatment of Lymphedema | Biotech Hunter | Biotech Hunter